TCHP and neoplasm: IFNα enhances immune recognition by increasing class I and II MHC molecules expressions surfaced on tumor cells and it is regarded as a potential treatment strategy by directly blocking cell-cycle progression and promoting apoptosis, thus suppressing tumor extension through stimulating the expression of antitumor IFN-stimulated gene products and tumor suppressor proteins (13, 14).